Seeking Alpha

Alkermes Inc. (ALKS)

()

News & PR
Market Currents

Buzz
Twitter: ALKS

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

Wall Street Breakfast: Must-Know News
Nov 5, 2008 • SA Editor Eli Hoffmann • ABK, AGU, ALKS • 20 Comments
Wall Street Breakfast: Must-Know News
Aug 7 • SA Editor Rachael Granby • AGO, AIG, ALKS • 18 Comments
Biotech Opportunities: Look for Decent Pipeline, Big Pharma Partnerships
Jun 2 • Zacks.com • ALKS, AMAG, CRA • 15 Comments
Generex Biotechnology: Oral-lyn Buccal Insulin Takes Center Stage
Apr 10, 2008 • R.J Steffens • ALKS, GNBT, MNKD • 13 Comments
Wall Street Breakfast: Must-Know News
May 22 • SA Editor Eli Hoffmann • ADSK, AIG, ALKS • 13 Comments
Why I'm Buying Amylin Now
Aug 20, 2008 • TraderMark • ALKS, AMLN, MRK • 10 Comments
Wall Street Breakfast: Must-Know News
May 23, 2008 • SA Editor Eli Hoffmann • AAPL, ADBE, ALKS • 7 Comments
Alkermes, Lilly, Mannkind: Inhaled Insulin Just Got Interesting
Jan 22, 2008 • Michael Shulman • ALKS, LLY, MNKD • 5 Comments
Alkermes Should Profit From Lilly's Delayed Drug
Feb 29, 2008 • Notable Calls • ALKS, LLY • 3 Comments
Which Diabetes Drugs Will Win Out?
Apr 2 • Mike Huckman • ALKS, AMLN, AZN • 3 Comments
FDA Calendar: 2H09 Binary Event Trades
Jul 27 • Mike Havrilla • ACAD, AEZS, ALKS • 3 Comments
FDA Calendar Updates: Amylin, Alkermes, Eli Lilly, Cell Therapeutics
May 6 • Mike Havrilla • ALKS, AMLN, CTIC • 3 Comments
Three Recent Biotech Activist Wins by Carl Icahn
Aug 31 • Michael Becker • ALKS, AMLN, AZN • 3 Comments
FDA Calendar Updates: Acusphere, AspenBio, Alkermes
May 19 • Mike Havrilla • ACUS, ALKS, APPA • 3 Comments
Nine Pharma Predictions for 2009
Dec 2, 2008 • Mike Huckman • ALKS, AMGN, AMLN • 2 Comments
Eli Lilly's CEO: 'Ludicrous' Stock Price
Dec 12, 2008 • Mike Huckman • ALKS, AMLN, LLY • 2 Comments
Monthly Big 5: Stocks Worth Watching
Feb 4 • GT McDuffy • ALKS, GTCB, JNJ • 2 Comments
15 'Bathwater Babies' and 20 'Dogs with Fleas' for the Week
Apr 5 • J Clinton Hill • AEM, AIPC, ALKS • 2 Comments
Is Lilly and Amylin's Byetta Better?
Jun 11, 2008 • Mike Huckman • ALKS, AMLN, LLY • 2 Comments
Wednesday Options Recap
Nov 11 • Frederic Ruffy • ALKS, AMAT, CRM • 2 Comments
Did Inside Connections Influence Glaxo's Bid For Reliant?
Nov 22, 2007 • NewsVisual • ALKS, GSK • 1 Comment
Aradigm: Hard to Value, But Significant Upside
Jun 19 • Zacks.com • ALKS, ALXA, ARDM.OB • 1 Comment
Eat It, Breathe It, Soak in It? Drug Administration Gets Tricky
Jan 20, 2008 • Derek Lowe • ALKS, ARDM.OB, LLY • 1 Comment
Updated FDA Calendar: Cypress Bioscience Looks Like a Buy
Dec 12, 2008 • Mike Havrilla • ACUS, ALKS, ALO • 1 Comment
30 Possible Pandemic Profit Plays: Bullish Biotech and Drug Stocks to Watch
Jun 28 • Marco Hickey • ABAX, ACOR, ALKS • 1 Comment
74 Solid, Growing Companies in a Recession
Jun 30 • Davy Bui • AAON, ACN, ALGN • 1 Comment
Smaller Pharma Wins the 'Most Valuable' Race
Jul 1 • EP Vantage • ALKS, AMGN, CELG • 1 Comment
Early Filing for Byetta: Will It Become a Blockbuster?
May 6 • Mike Huckman • ALKS, AMLN, LLY • 1 Comment
Who Will Win the Amylin Battle?
May 7 • Mike Huckman • ALKS, AMLN, BTK • 1 Comment
Recessionary Equity Strategies: Still Going for Growth
Nov 5, 2008 • Marc Gerstein • ALKS, ANDE, AOI • 1 Comment

Alkermes Inc. (ALKS)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers